Shots:
Orna & Vertex have entered into a 3yrs. strategic research collaboration to utilize the former’s LNP delivery solutions for supporting the development of next-gen. gene editing therapies for SCD & TDT, with Vertex funding the partnership
As per the terms, Orna will get $65M upfront (incl. investment in the form of a convertible…
